Skip to main content
SpringerLink
Log in
Book cover

Human Growth Hormone pp 285–295Cite as

Growth Hormone in AIDS

  • Chapter

  • 235 Accesses

Part of the book series: Contemporary Endocrinology ((COE,volume 19))

Abstract

Body wasting is a frequent and potentially devastating complication of human immunodeficiency virus (HIV) infection. As widespread use of prophylaxis against opportunistic infections and other treatment strategies has effectively delayed the onset of classic AIDS-indicating illnesses, the prominence of the wasting syndrome as an AIDS-defining condition has increased (1,2). In a large cohort study in the United States, the wasting syndrome was the AIDS-defining condition in 18% of those who had received prophylaxis against P. carinii pneumonia (PCP), when compared with 6% of those who did not (2). Among patients followed at a naval medical facility, wasting accounted for 31% of AIDS diagnoses in 1992 as compared to only 6% in 1988 (1). Epidemiological data suggest that women are at similar risk for wasting as men (3,4).

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   89.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Weiss PJ, Wallace MR, Olson PE, Rossetti R. Change in the mix of AIDS-defining conditions. N Engl J Med 1993; 329: 1962.

    Article  PubMed  CAS  Google Scholar 

  2. Hoover DR, Saah AJ, Bacellar H, Phair J, Detels R, Anderson R, Kaslow RA. Clinical manifestations of AIDS in the era of pneumocystis prophylaxis. N Engl J Med 1993; 329: 1922–1926.

    Article  PubMed  CAS  Google Scholar 

  3. Nahlen BL, Chu SY, Nwanyanwu OC, Berkelman RL, Martinez SA, Rullan JV. HIV wasting syndrome in the United States. AIDS 1993; 7: 183–188.

    CAS  Google Scholar 

  4. Melnick SL, Sherer R, Louis TA, Hillman D, Rodriguez EM, Lackman C, Capps L, Brown LS Jr, Carlyn M, Korvick JA, Deyton L. Survival and disease progression according to gender of patients with HIV infection. JAMA 1994; 272: 1915–1921.

    CAS  Google Scholar 

  5. Kotler DP, Tierney AR, Wang J, Pierson RN Jr. Magnitude of body-cell-mass depletion and the timing of death from wasting in AIDS. Am J Clin Nutr 1989; 50: 444–447.

    PubMed  CAS  Google Scholar 

  6. Brozek J, Wells S, Keys A. Medical aspects of semistarvation in Leningrad (siege 1941–1942). Am Rev Soviet Med 1946; 4: 70–86.

    CAS  Google Scholar 

  7. Fliederbaum J. Clinical aspects of hunger disease in adults. In: Winick M, ed. Hunger Disease: Studies by the Jewish Physicians in the Warsaw Ghetto. Wiley, New York, 1979, pp. 11–43.

    Google Scholar 

  8. Palenicek JG, Graham NMH, He YD, Hoover DA, Oishi JS, Kingsley L, Saah AJ. Weight loss prior to clinical AIDS as a predictor of survival. J Acquire Immune Defic Syndr 1995; 10: 366–373.

    CAS  Google Scholar 

  9. Suttmann U, Ockenga J, Selberg O, Hoogestraat L, Deicher H, Muller MJ. Incidence and prognostic value of malnutrition and wasting in human immunodeficiency virus-infected patients. J Acquire Immune Defic Syndr 1995; 8: 239–246.

    Article  CAS  Google Scholar 

  10. Ott M, Fischer H, Polat H, Helm EB, Frenz M, Caspary WF, Lembcke B. Bioelectrical impedance analysis as a predictor of survival in patients with human immunodeficiency virus infection. J Acquire Immune Defic Syndr 1995; 9: 20–25.

    CAS  Google Scholar 

  11. Wheeler DA, Gibert CL, Launer CA, Muurahainen N, Elion RA, Abrams DI, Bartsch GE. Weight loss as a predictor of survival and disease progression in HIV infection. J Acquire Immune Defic Syndr 1998; 18: 80–85.

    Article  CAS  Google Scholar 

  12. Guenter P, Muurahainen N, Kosok A, Cohan GR, Rudenstein R, Turner JL. Relationships among nutritional status, disease progression, and survival in HIV infection. J Acquire Immune Defic Syndr 1993; 6: 1130–1138.

    CAS  Google Scholar 

  13. Ehrenpreis ED, Ganger DR, Kochvar GT, Patterson BK, Craig RM. D-xylose malabsorption: characteristic finding in patients with AIDS wasting syndrome and chronic diarrhea. J Acquire Immune Defic Syndr 1992; 5: 1047–1050.

    CAS  Google Scholar 

  14. Turner J, Muurahainen N, Terrell C, Graeber C, Kotler D. Nutritional status and quality of life. Xth Int Conf AIDS 1994; 431B.

    Google Scholar 

  15. Grunfeld C, Kotler DP, Hamadeh R, Tierney A, Wang J, Pierson RN Jr. Hypertriglyceridemia in the acquired immunodeficiency syndrome. Am J Med 1989; 86: 27–31.

    Article  PubMed  CAS  Google Scholar 

  16. Grunfeld C, Kotler DP, Shigenga JK, Doerrler W, Tierney A, Wang J, Pierson RN Jr, Feingold KR. Circulating interferon alpha levels and hypertriglyceridemia in the acquired immunodeficiency syndrome. Am J Med 1991; 90: 154–162.

    PubMed  CAS  Google Scholar 

  17. Grunfeld C, Pang M, Shimizu L, Shigenaga JK, Jensen P, Feingold KR. Resting energy expenditure, caloric intake and short-term weight change in human immunodeficiency virus infection and the acquired immunodeficiency syndrome. Am J Clin Nutr 1992; 55: 455–460.

    PubMed  CAS  Google Scholar 

  18. Macallan DC, Noble C, Baldwin C, Foskett M, McManus T, Griffin GE. Prospective analysis of patterns of weight change in stage IV HIV infection. Am J Clin Nutr 1993; 58: 417–424.

    PubMed  CAS  Google Scholar 

  19. Kotler DP, Wang J, Pierson RN Jr. Body composition studies in patients with the acquired immunodeficiency syndrome. Am J Clin Nutr 1985; 42: 1255–1265.

    PubMed  CAS  Google Scholar 

  20. Ott M, Lembcke B, Fischer H, Jager R, Polat H, Geier H, Rech M, Staszeswki S, Helm EB, Caspary WF. Early changes of body composition in human immunodeficiency virus-infected patients: tetrapolar body impedance analysis indicates significant malnutrition. Am J Clin Nutr 1993; 57: 15–19.

    PubMed  CAS  Google Scholar 

  21. Sharkey SJ, Sharkey KA, Sutherland LR, Church DL. Nutritional status and food intake in human immunodeficiency virus infection. J Acquire Immune Defic Syndr 1992; 5: 1091–1098.

    CAS  Google Scholar 

  22. Sharpstone D, Murray C, Ross H, Hancock M, Phelan M, Crane R, Menzies I, Reaveley D, Lepri A, Nelson M, Gazzard B. Energy balance in asymptomatic HIV infection. AIDS 1996; 10: 1377–1384.

    CAS  Google Scholar 

  23. Paton N, Macallan D, Jebb S, Noble C, Baldwin C, Pazianas M, Griffin G. Longitudinal changes in body composition measured with a variety of methods in patients with AIDS. J Acquire Immune Defic Syndr 1997; 14: 119–127.

    Article  CAS  Google Scholar 

  24. Mulligan K, Tai VW, Schambelan M. Cross-sectional and longitudinal evaluation of body composition in men with HIV infection. J Acquire Immune Defic Syndr 1997; 15: 43–48.

    Article  CAS  Google Scholar 

  25. Suttmann U, Ockenga J, Hoogestraat L, Selberg O, Deicher H, Muller MJ. Resting energy expenditure and weight loss in human immunodeficiency virus-infected patients. Metabolism 1993; 42: 1173–1179.

    Article  PubMed  CAS  Google Scholar 

  26. Grunfeld C, Feingold KR. Metabolic disturbances and wasting in the acquired immunodeficiency syndrome. N Engl J Med 1992; 327: 329–337.

    Article  PubMed  CAS  Google Scholar 

  27. Melchior J-C, Salmon D, Rigaud D, Leport C, Bouvet E, Detruchis P, Vilde J-L, Vachon F, Couland J-P, Apfelbaum M. Resting energy expenditure is increased in stable, malnourished HIV-infected patients. Am J Clin Nutr 1991; 53: 437–441.

    PubMed  CAS  Google Scholar 

  28. Hommes MJT, Romijn JA, Endert E, Sauerwein HP. Resting energy expenditure and substrate oxidation in human immunodeficiency virus (HIV)-infected asymptomatic men: HIV affects host metabolism in the early asymptomatic stage. Am J Clin Nutr 1991; 54: 311–315.

    PubMed  CAS  Google Scholar 

  29. Melchior J-C, Raguin G, Boulier A, Bouvet E, Rigaud D, Matheron S, Casalino E, Vilde J-L, Vachon F, Couland J-P, Apfelbaum M. Resting energy expenditure in human immunodeficiency virus-infected patients: comparison between patients with and without secondary infections. Am J Clin Nutr 1993; 57: 614–619.

    PubMed  CAS  Google Scholar 

  30. Mulligan K, Grunfeld C, Hellerstein MK, Neese RA, Schambelan M. Anabolic effects of recombinant human growth hormone in patients with wasting associated with human immunodeficiency virus infection. J Clin Endocrinol Metab 1993; 77: 956–962.

    Article  PubMed  CAS  Google Scholar 

  31. Macallan DC, Noble C, Baldwin C, Jebb SA, Prentice AM, Coward WA, Sawyer MB, McManus TJ, Griffin GE. Energy expenditure and wasting in human immunodeficiency virus infection. N Engl J Med 1995; 333: 83–88.

    Article  PubMed  CAS  Google Scholar 

  32. Macallan DC, McNurlan MA, Milne E, Calder AG, Garlick PJ, Griffin GE. Whole-body protein turnover from leucine kinetics and the response to nutrition in human immunodeficiency virus infection. Am J Clin Nutr 1995; 61: 818–826.

    PubMed  CAS  Google Scholar 

  33. Kotler DP, Tierney AR, Culpepper-Morgan JA, Wang J, Pierson RN Jr. Effect of home total parenteral nutrition on body composition in patients with acquired immunodeficiency syndrome. JPEN 1990; 14: 454–458.

    CAS  Google Scholar 

  34. Melchior J, Chastang C, Gelas P, Carbonnel F, Zazzo J, Boulier A, Cosnes J, Bouletreau P, Messing B. Efficacy of 2-month total parenteral nutrition in AIDS patients: a controlled randomized prospective trial. AIDS 1996; 10: 379–384.

    CAS  Google Scholar 

  35. Von Roenn JH, Armstrong D, Kotler DP, Cohn DL, Klimas NG, Tchekmedyian NS, Cone L, Brennan PJ, Weitzman SA. Megestrol acetate in patients with AIDS-related cachexia. Ann Intern Med 1994; 121: 393–399.

    Google Scholar 

  36. Oster MH, Enders SR, Samuels SJ, Cone LA, Hooton TM, Browder HP, Flynn NM. Megestrol acetate in patients with AIDS and cachexia. Ann Intern Med 1994; 121: 400–408.

    PubMed  CAS  Google Scholar 

  37. Salbe AD, Kotler DP, Wang J, Pierson RN Jr, Campbell RG. Correlation between serum insulin-like growth factor I (IGFI) concentrations and nutritional status in HIV-infected individuals. Nutr Res 1995; 15: 1437–1443.

    Article  CAS  Google Scholar 

  38. Frost RA, Fuhrer J, Steigbeigel R, Mariuz P, Lang CH, Gelato MC. Wasting in the acquired immune deficiency syndrome is associated with multiple defects in the serum insulin-like growth factor system. Clinical Endocrinology 1996; 44: 501–514.

    Article  PubMed  CAS  Google Scholar 

  39. Lieberman SA, Butterfield GE, Harrison D, Hoffman AR. Anabolic effects of recombinant insulin-like growth factor-I in cachectic patients with the acquired immunodeficiency syndrome. J Clin Endocrinol Metab 1994; 78: 404–410.

    Article  PubMed  CAS  Google Scholar 

  40. Gelato MC, Frost RA, DeCristofaro K, Garlick PJ, Lang CH, Steigbigel R, Fuhrer J, McNurlan MA. Growth hormone (GH) deficiency and diminished anabolic response in muscle of HIV infected patients. 10th Int Cong Endocrinology 1996; 1: 253.

    Google Scholar 

  41. Ward HC, Halliday D, Sim AJW. Protein and energy metabolism with biosynthetic human growth hormone after gastrointestinal surgery. Ann Surg 1987; 206: 56–61.

    Article  PubMed  CAS  Google Scholar 

  42. Ziegler TR, Young LS, Ferrari-Baliviera E, Demling RH, Wilmore DW. Use of human growth hormone combined with nutritional support in a critical care unit. JPEN 1990; 14: 574–581.

    CAS  Google Scholar 

  43. Manson JM, Wilmore DW. Positive nitrogen balance with human growth hormone and hypocaloric intravenous feeding. Surgery 1986; 100: 188–197.

    PubMed  CAS  Google Scholar 

  44. Forbes GB. Body composition: influence of nutrition, disease, growth and aging. In: Shils ME, Young VR, eds. Modern Nutrition in Health and Disease. Lea & Febiger, Philadelphia, 1988, pp. 533–556.

    Google Scholar 

  45. Krentz AJ, Koster FT, Crist DM, Finn K, Johnson LZ, Boyle PJ, Schade DS. Anthropometric, metabolic, and immunological effects of recombinant human growth hormone in AIDS and AIDS-related complex. J Acquire Immune Defic Syndr 1993; 6: 245–251.

    CAS  Google Scholar 

  46. Schambelan M, Mulligan K, Grunfeld C, Daar ES, LaMarca A, Kotler DP, Wang J, Bozzette SA, Breitmeyer JB. Recombinant human growth hormone in patients with HIV-associated wasting: a randomized, placebo-controlled trial. Ann Intern Med 1996; 125: 873–882.

    PubMed  CAS  Google Scholar 

  47. Berry SH, Bozzette SA, Hays RD, Stewart AL, Kanouse DE. Measuring patient reported health status in advanced HIV disease: HIV-PARSE survey instrument. MR-342-NIAID/SDAC, 1994.

    Google Scholar 

  48. Waters D, Danska J, Hardy K, Koster F, Qualls C, Nickell D, Nightingale S, Gesundheit N, Watson D, Schade D. Recombinant human growth hormone, insulin-like growth factor I, and combination therapy in AIDS-associated wasting: a randomized, double-blind, placebo-controlled trial. Ann Intern Med 1996; 125: 865–872.

    PubMed  CAS  Google Scholar 

  49. Mulligan K, Tai VW, Schambelan M. Effects of chronic growth hormone treatment on energy intake and resting energy metabolism in patients with HIV-associated wasting. J Clin Endocrinol Metab 1998; 83: 1542–1547.

    Article  PubMed  CAS  Google Scholar 

  50. Guler H-P, Zapf J, Scheiwiller E, Froesch ER. Recombinant human insulin-like growth factor I stimulates growth and has distinct effects on organ size in hypophysectomized rats. Proc Natl Acad Sci USA 1988; 85: 4889–4893.

    Article  PubMed  CAS  Google Scholar 

  51. Clemmons DR, Smith-Banks A, Underwood LE. Reversal of diet-induced catabolism by infusion of recombinant insulin-like growth factor-I in humans. J Clin Endocrinol Metab 1992; 75: 234–238.

    Article  PubMed  CAS  Google Scholar 

  52. Kupfer AR, Underwood LE, Baxter RC, Clemmons DR. Enhancement of the anabolic effects of growth hormone and insulin-like growth factor I by use of both agents simultaneously. J Clin Invest 1993; 91: 391–396.

    Article  PubMed  CAS  Google Scholar 

  53. Mulligan K, Schambelan M. Growth hormone and other pharmacologic interventions. In: Gorbach SL, Miller TL, eds. Nutritional Aspects of HIV Infection. Thomson Science, Philadelphia (in press), 1997.

    Google Scholar 

  54. Hommes MJT, Romijn JA, EndertE, Eeftinck-SchattenkerkJKM, Sauerwein HP. Insulin sensitivity and insulin clearance in human immunodeficiency virus-infected men. Metabolism 1991; 40: 651–656.

    Article  PubMed  CAS  Google Scholar 

  55. Heijligenberg R, Romijn JA, Hommes MJT, Endert E, Eeftinck-Schattenkerk JKM, Sauerwein HP. Non-insulin-mediated glucose uptake in human immunodeficiency virus-infected men. Clin Sci 1993; 84: 209–216.

    Google Scholar 

  56. Lee PDK, Pivarnik JM, Bukar JG, Muurahainen N, Berry PS, Skolnik PR, Nerad JL, Kudsk KA, Jackson L, Ellis KJ, Gesundheit N. A randomized, placebo-controlled trial of combined insulin-like growth factor I and low dose growth hormone therapy for wasting associated with human immunodeficiency virus infection. J Clin Endocrinol Metab 1996; 81: 2968–2975.

    Article  PubMed  CAS  Google Scholar 

  57. Ellis KJ, Lee PDK, Pivarnik JM, Bukar JG, Gesundheit N. Changes in body composition of human immunodeficiency virus-infected males receiving insulin-like growth factor-I and growth hormone. J Clin Endocrinol Metab 1996; 81: 3033–3038.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. Kathleen Mulligan PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Morris Schambelan MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Huffington Center on Aging and Department of Cell Biology, Baylor College of Medicine, Houston, TX, USA

    Roy G. Smith PhD

  2. Department of Medicine, University of Virginia Health Sciences Center, Charlottesville, VA, USA

    Michael O. Thorner MD

Rights and permissions

Reprints and permissions

Copyright information

© 2000 Humana Press Inc., Totowa, NJ

About this chapter

Cite this chapter

Mulligan, K., Schambelan, M. (2000). Growth Hormone in AIDS. In: Smith, R.G., Thorner, M.O. (eds) Human Growth Hormone. Contemporary Endocrinology, vol 19. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-015-5_17

Download citation

  • DOI: https://doi.org/10.1007/978-1-59259-015-5_17

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-4684-9610-9

  • Online ISBN: 978-1-59259-015-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation